Announcements
- Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
- Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023
- Immutep’s Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer
Key statistics
On Monday, Immutep Ltd (YP1B:DEU) closed at 0.174, 34.06% above the 52 week low of 0.1298 set on Aug 29, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.176 |
---|---|
High | 0.189 |
Low | 0.165 |
Bid | 0.174 |
Offer | 0.19 |
Previous close | 0.174 |
Average volume | 12.01k |
---|---|
Shares outstanding | 1.45bn |
Free float | 1.41bn |
P/E (TTM) | -- |
Market cap | 421.26m AUD |
EPS (TTM) | -0.039 AUD |
Data delayed at least 15 minutes, as of Jul 22 2024.
More ▼